1 EVERTRUST PLAZA, JERSEY CITY, NJ
Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247
Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
Announces Appointment of Sanjay Subramanian as Chief Financial Officer
SCYNEXIS Increases Authorized Shares to 65 Million; Stockholder Approval Rece...
SCYNEXIS, Inc. Implements 1-for-8 Reverse Stock Split and Share Reduction
Material disclosure
Director Retirement - Steven C. Gilman Steps Down from SCYNEXIS Board
Investor Presentation
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Correspondence
Submission Upload
Free Writing Prospectus